EGFR and breast cancer: Four genes from breast cancer stage III network pattern (KRT8, KRT17, KRT18 and HOXC10) physically interact with EGFR, a target gene of Lapatinib Breast cancer drug which is quite similar (greater than 50%) to Paroxetine (repurposed drug from LINCS).